Warning! GuruFocus detected
1 Severe warning sign
with INKT.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
MiNK Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US6036931029
Description
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.93 | |||||
| Equity-to-Asset | -3.42 | |||||
| Debt-to-Equity | -0.25 | |||||
| Debt-to-EBITDA | -0.47 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 27 | |||||
| 3-Year EPS without NRI Growth Rate | 30.4 | |||||
| 3-Year FCF Growth Rate | 20.4 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.52 | |||||
| 9-Day RSI | 50.86 | |||||
| 14-Day RSI | 49.63 | |||||
| 3-1 Month Momentum % | 82.61 | |||||
| 6-1 Month Momentum % | 27.11 | |||||
| 12-1 Month Momentum % | 5.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.72 | |||||
| Quick Ratio | 0.72 | |||||
| Cash Ratio | 0.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.8 | |||||
| Shareholder Yield % | -17.15 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -154.66 | |||||
| ROIC % | -330.92 | |||||
| 3-Year ROIIC % | -242.78 | |||||
| ROC (Joel Greenblatt) % | -1258.39 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -3.22 | |||||
| EV-to-Forward-EBIT | -2.77 | |||||
| EV-to-EBITDA | -3.29 | |||||
| EV-to-FCF | -3.59 | |||||
| Earnings Yield (Greenblatt) % | -31.06 | |||||
| FCF Yield % | -28.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:INKT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MiNK Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.96 | ||
| Beta | 0.15 | ||
| 3-Year Sharpe Ratio | -0.3 | ||
| 3-Year Sortino Ratio | -0.57 | ||
| Volatility % | 38.87 | ||
| 14-Day RSI | 49.63 | ||
| 14-Day ATR ($) | 1.020717 | ||
| 20-Day SMA ($) | 8.40078 | ||
| 12-1 Month Momentum % | 5.27 | ||
| 52-Week Range ($) | 4.5601 - 19 | ||
| Shares Outstanding (Mil) | 3.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MiNK Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MiNK Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MiNK Therapeutics Inc Frequently Asked Questions
What is MiNK Therapeutics Inc(INKT)'s stock price today?
The current price of INKT is $8.57. The 52 week high of INKT is $19.00 and 52 week low is $4.56.
When is next earnings date of MiNK Therapeutics Inc(INKT)?
The next earnings date of MiNK Therapeutics Inc(INKT) is 2025-05-14 Est..
Does MiNK Therapeutics Inc(INKT) pay dividends? If so, how much?
MiNK Therapeutics Inc(INKT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers